T細胞のためのCRISPRツール:ゲノム,エピゲノム,トランスクリプトームをターゲットにする
PubMedで要約を見る
まとめ
この要約は機械生成です。CRISPRの遺伝子編集は 癌治療におけるT細胞治療の課題に 新たな解決策を提供し 固体腫瘍の有効性とアクセシビリティを向上させています この技術は 次世代のがん治療のために T細胞を改良します
科学分野
- 免疫学
- 遺伝学
- バイオテクノロジー
背景
- T細胞治療は がんに対して有望ですが 反応の持続時間,抗原の脱出,固体腫瘍治療などの課題に直面しています
- 現在の制限はT細胞治療の広範な適用と有効性を阻害しています.
研究 の 目的
- T細胞工学のCRISPR技術の進歩をレビューする.
- CRISPRが現在のT細胞治療の限界を 克服する方法を探るためです
- CRISPRベースの細胞治療の 将来の方向性を強調するためです
主な方法
- CRISPRシステムの最近の技術的進歩のレビュー
- T細胞工学におけるCRISPRの応用に関する分析
- 新しい応用と限界の議論
主要な成果
- CRISPR技術は 遺伝子ノックアウトを超えて 精巧なゲノム・エピゲノム・トランスクリプトーム工学へと進化しました
- CRISPRはT細胞治療の課題に 効果的な治療法と 固体腫瘍の治療法を 提供しています
結論
- CRISPR技術は T細胞治療の進歩に不可欠です
- CRISPRツールの将来的な開発は 現在の限界に対処し 治療の可能性を広げます
- CRISPRで作られたT細胞は 次世代の細胞がん治療法です
関連する概念動画
The CRISPR-Cas system serves as a bacterial defense mechanism against invading genetic elements such as viruses and plasmids, forming the foundation for its adaptation as a powerful genome-editing tool. Originally discovered in prokaryotes, this system has been repurposed to revolutionize genetic engineering across a wide range of organisms, including plants, animals, and humans. The core component, Cas9, is an endonuclease derived from Streptococcus pyogenes, capable of introducing...
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
Bacteria and archaea are susceptible to viral infections just like eukaryotes; therefore, they have developed a unique adaptive immune system to protect themselves. Clustered regularly interspaced short palindromic repeats and CRISPR-associated proteins (CRISPR-Cas) are present in more than 45% of known bacteria and 90% of known archaea.
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
Because the DNA segments are cut and reorganized in a direction-specific manner, site-specific recombination has emerged as an efficient genetic engineering technique. Flippase and Cyclization recombinases or Flp and Cre, respectively, are two members of the tyrosine recombinase family derived from bacteriophages, that are used to mediate site-specific DNA insertions, deletions, and targeted expression of proteins in mammalian cell lines.
The recognition sites for Cre recombinase called LoxP...
The basic reaction of homologous recombination (HR) involves two chromatids that contain DNA sequences sharing a significant stretch of identity. One of these sequences uses a strand from another as a template to synthesize DNA in an enzyme-catalyzed reaction. The final product is a novel amalgamation of the two substrates. To ensure an accurate recombination of sequences, HR is restricted to the S and G2 phases of the cell cycle. At these stages, the DNA has been replicated already and the...

